Vaccentis
VACCENTIS FOCUSES ON DEVELOPING IMMUNO-ONCOLOGY VACCINES UTILISING ITS AUTOLOGOUS TUMOUR VACCINE TECHNOLOGY PLATFORM
5 employees · est. 2006 · Zurich, Switzerland
Vaccentis is the older company (2010 vs 2006); Oncoinvent ASA is the larger of the two.
Side-by-Side Comparison
| Metric | Oncoinvent ASA | Vaccentis |
|---|---|---|
| Founded | ||
| Founded | 2010 | 2006 older |
| Headquarters | ||
| Headquarters | Oslo, Norway | Zurich, Switzerland |
| Employees | ||
| Employees | 47 larger | 5 |
| Industry | ||
| Industry | Biotechnology, Life Sciences | Health Care |
| Funding Stage | ||
| Funding Stage | Series Unknown | Not tracked yet |
| Total Funding | ||
| Total Funding | $281.00M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 3 | Not tracked yet |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Oncoinvent, Radiopharmaceuticals, Radspherin, Alpha-emitting Radionuclides, Cancer Treatment, Clinical Stage Company, Metastatic Cancers, Radiotherapeutic Products, Radioimmunotherapeutic Products, Solid Cancers, Clinical Trials, Oslo, Laboratory Facilities, CGMP | Immunotherapy, Cancer Vaccines, Oncology, Tumor Vaccine Technology, Autoimmune Oncology, Renal Cell Carcinoma, Metastatic Cancer Treatment, Clinical Research, Patient-Specific Medicines, Evidence-Based Medicine, Medical Product Development, Natural Medicine, Biopharmaceuticals |
| Website | ||
| Website | oncoinvent.com | vaccentis.com |
About Oncoinvent ASA
Oncoinvent AS is a biotechnology startup based in Norway that was founded in 2010. The company's slogan, "Innovations for better cancer care," encapsulates its mission to develop new and innovative radiopharmaceutical products for improved treatment options for cancer patients. Its lead product cand...
About Vaccentis
Vaccentis is a health care startup with a focus on developing immuno-oncology vaccines utilizing its autologous tumor vaccine technology platform. The company was founded in 2006 and is currently in the late stage development of an autologous tumor vaccine for Renal Cell Carcinoma. Their medical div...
We will tell you when either one moves
BounceWatch watches Oncoinvent ASA and Vaccentis for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Oncoinvent ASA and Vaccentis — by email.
Frequently Asked Questions
Compare Oncoinvent ASA with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Oncoinvent ASA on 11 Sep 2024, and Vaccentis on 17 Nov 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.